News & Announcements

January 23, 2018

The biotech manufacturing company is expanding within the University of Maryland BioPark, as well as to a new facility in Anne Arundel County.

Paragon Bioservices has plans to expand to new space over the next two years to help companies develop and manufacture biopharmaceuticals.

The company said Tuesday it is planning to add 10,000 sq. ft. to its current space at the University of Maryland BioPark in Baltimore. The offices are located at 801 W. Baltimore St.

The expansion is also stretching beyond the city. Additionally, Paragon will open a 150,000 sq. ft. facility near BWI in Anne Arundel County. The space will have more room for manufacturing and research lab space. Initial manufacturing capabilities are expected to be up and running in the fourth quarter of this year.

Paragon Biopharmaceuticals has expertise in helping development of new gene therapy, as well as what it calls “next-generation vaccines.” It helps pharmaceutical companies move through trials and scale production of new treatments. The 30-year-old company’s recent growth came following a $13 million Series A in 2014, which was backed by Baltimore-based private equity firm Camden Partners and Radnor, Pa.–based NewSpring Capital.